RxDoctor Payments DataLook up a doctor →

Stephen Miller

Dermatology · San Antonio, TXNPI 1760454060

Payments from drug & device makers

$388,595in general payments, 2019–2025

Across 678 payments — averaging $573.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$127K
  • Eli Lilly$119K
  • AbbVie$82K
  • Pfizer$35K
  • Galderma Research & Development, LLC$15K
  • Sun Pharmaceutical Industries Inc.$1K
  • plus $9K from 33 others
$180,650in research payments, 2019–2025

Across 10 payments — averaging $18,065 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Amgen$176K
  • Dr.reddy's Laboratories,inc.$4K
  • Eli Lilly$795

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$388,595 in reported general payments places this provider in the 95th percentile of 1,098 dermatology providers in Texas.

See all dermatology providers in Texas

Medicare billing

Part B allowed, 2024
$274,835
Medicare patients
555
Services billed
7,274

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other dermatology in San Antonio

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →